193 related articles for article (PubMed ID: 20045984)
21. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes.
Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN
Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332
[TBL] [Abstract][Full Text] [Related]
22. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
[TBL] [Abstract][Full Text] [Related]
23. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution.
Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T
Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316
[TBL] [Abstract][Full Text] [Related]
24. Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation.
Uchaipichat V; Raungrut P; Chau N; Janchawee B; Evans AM; Miners JO
Drug Metab Dispos; 2011 Aug; 39(8):1324-8. PubMed ID: 21551257
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory Effect of Sauchinone on UDP-Glucuronosyltransferase (UGT) 2B7 Activity.
You BH; Gong EC; Choi YH
Molecules; 2018 Feb; 23(2):. PubMed ID: 29425147
[TBL] [Abstract][Full Text] [Related]
26. Herbal medicine and false-positive results on lymphocyte transformation test.
Mantani N; Sakai S; Kogure T; Goto H; Shibahara N; Kita T; Shimada Y; Terasawa K
Yakugaku Zasshi; 2002 Jun; 122(6):399-402. PubMed ID: 12087777
[TBL] [Abstract][Full Text] [Related]
27. Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones.
Herber R; Magdalou J; Haumont M; Bidault R; van Es H; Siest G
Biochim Biophys Acta; 1992 Jun; 1139(1-2):20-4. PubMed ID: 1610916
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory Effects of Baicalein Derived from Japanese Traditional Herbal Medicine on SN-38 Glucuronidation.
Satoh T; Igarashi A; Tanno M; Yamada K; Takahashi-Suzuki N; Watanabe K
J Pharm Pharm Sci; 2018; 21(1):195-206. PubMed ID: 29891024
[TBL] [Abstract][Full Text] [Related]
29. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.
King C; Tang W; Ngui J; Tephly T; Braun M
Toxicol Sci; 2001 May; 61(1):49-53. PubMed ID: 11294973
[TBL] [Abstract][Full Text] [Related]
30. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
[TBL] [Abstract][Full Text] [Related]
31. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
[TBL] [Abstract][Full Text] [Related]
32. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
[TBL] [Abstract][Full Text] [Related]
33. In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction.
Rowland A; Elliot DJ; Williams JA; Mackenzie PI; Dickinson RG; Miners JO
Drug Metab Dispos; 2006 Jun; 34(6):1055-62. PubMed ID: 16565174
[TBL] [Abstract][Full Text] [Related]
34. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms.
Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N
Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425
[TBL] [Abstract][Full Text] [Related]
35. Identification of human UDP-glucuronosyltransferase isoforms responsible for the glucuronidation of glycyrrhetinic acid.
Lu Y; Zhu J; Chen X; Li N; Fu F; He J; Wang G; Zhang L; Zheng Y; Qiu Z; Yu X; Han D; Wu L
Drug Metab Pharmacokinet; 2009; 24(6):523-8. PubMed ID: 20045987
[TBL] [Abstract][Full Text] [Related]
36. Glucuronidation of 3'-azido-3'-deoxythymidine catalyzed by human liver UDP-glucuronosyltransferase. Significance of nucleoside hydrophobicity and inhibition by xenobiotics.
Resetar A; Minick D; Spector T
Biochem Pharmacol; 1991 Jul; 42(3):559-68. PubMed ID: 1907149
[TBL] [Abstract][Full Text] [Related]
37. Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver.
Mano Y; Usui T; Kamimura H
Eur J Clin Pharmacol; 2007 Mar; 63(3):289-96. PubMed ID: 17245571
[TBL] [Abstract][Full Text] [Related]
38. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
[TBL] [Abstract][Full Text] [Related]
39. Udp-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomes.
Bauman JN; Goosen TC; Tugnait M; Peterkin V; Hurst SI; Menning LC; Milad M; Court MH; Williams JA
Drug Metab Dispos; 2005 Sep; 33(9):1349-54. PubMed ID: 15980101
[TBL] [Abstract][Full Text] [Related]
40. In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes.
Takahashi K; Uejima E; Morisaki T; Takahashi K; Kurokawa N; Azuma J
J Clin Pharm Ther; 2003 Aug; 28(4):319-27. PubMed ID: 12911685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
